FDA Postpones All Foreign Inspections Over Coronavirus

As the ongoing COVID-19 outbreak continues to worsen, the U.S. Food and Drug Administration (FDA) announced that it will postpone all foreign inspections, effective immediately.

The agency said it won't conduct inspections of foreign manufacturing facilities until the end of April. However, inspections outside the country that are designated "mission-critical" will still be considered on a case-by-case basis.